Bank of New York Mellon’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-325,943
| Closed | -$12.9M | – | 4308 |
|
|
2024
Q1 | $12.9M | Buy |
325,943
+223,591
| +218% | +$8.86M | ﹤0.01% | 1831 |
|
|
2023
Q4 | $1.95M | Buy |
102,352
+9,629
| +10% | +$184K | ﹤0.01% | 2845 |
|
|
2023
Q3 | $1.06M | Buy |
92,723
+1,216
| +1% | +$13.9K | ﹤0.01% | 3113 |
|
|
2023
Q2 | $941K | Buy |
91,507
+19,701
| +27% | +$203K | ﹤0.01% | 3217 |
|
|
2023
Q1 | $554K | Sell |
71,806
-11,785
| -14% | -$91K | ﹤0.01% | 3440 |
|
|
2022
Q4 | $614K | Buy |
83,591
+19,111
| +30% | +$140K | ﹤0.01% | 3449 |
|
|
2022
Q3 | $464K | Buy |
64,480
+5,926
| +10% | +$42.6K | ﹤0.01% | 3603 |
|
|
2022
Q2 | $499K | Buy |
58,554
+9,399
| +19% | +$80.1K | ﹤0.01% | 3586 |
|
|
2022
Q1 | $441K | Sell |
49,155
-2,590
| -5% | -$23.2K | ﹤0.01% | 3787 |
|
|
2021
Q4 | $716K | Buy |
51,745
+1,207
| +2% | +$16.7K | ﹤0.01% | 3576 |
|
|
2021
Q3 | $539K | Buy |
50,538
+8,676
| +21% | +$92.5K | ﹤0.01% | 3767 |
|
|
2021
Q2 | $377K | Buy |
41,862
+19,178
| +85% | +$173K | ﹤0.01% | 3895 |
|
|
2021
Q1 | $240K | Sell |
22,684
-742
| -3% | -$7.85K | ﹤0.01% | 3988 |
|
|
2020
Q4 | $295K | Buy |
23,426
+12,088
| +107% | +$152K | ﹤0.01% | 3836 |
|
|
2020
Q3 | $100K | Buy |
+11,338
| New | +$100K | ﹤0.01% | 3954 |
|
|
2016
Q4 | – | Sell |
-4,124
| Closed | -$134K | – | 4316 |
|
|
2016
Q3 | $134K | Buy |
4,124
+298
| +8% | +$9.68K | ﹤0.01% | 3978 |
|
|
2016
Q2 | $70K | Sell |
3,826
-1,954
| -34% | -$35.8K | ﹤0.01% | 4123 |
|
|
2016
Q1 | $97K | Buy |
5,780
+2,393
| +71% | +$40.2K | ﹤0.01% | 3967 |
|
|
2015
Q4 | $105K | Buy |
3,387
+364
| +12% | +$11.3K | ﹤0.01% | 4020 |
|
|
2015
Q3 | $157K | Buy |
+3,023
| New | +$157K | ﹤0.01% | 3942 |
|